Johnson & Johnson (NYSE:JNJ) shares traded 0.17% up during most recent session to reach at the closing price of $139.41. The stock exchanged hands 6.45 Million shares versus average trading capacity of 9.5 Million shares, yielding a market cap of $371.75 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $144.71 within the next 52-weeks. The mean target projections are based on 17 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Johnson & Johnson (NYSE:JNJ) high price target of $160 and with a conservative view have low price target of $123.

Citigroup “Maintained” Johnson & Johnson (NYSE:JNJ) in a research note issued to investors on 2/25/19 to Neutral with price target of $147.

Additionally on 1/14/19 Wells Fargo “Maintained” Johnson & Johnson (NYSE:JNJ) to Outperform setting price target at $152 and on 1/02/19 Morgan Stanley “Maintained” the stock to Equal-Weight at $130. Furthermore on 1/02/19 Citigroup “Maintained” the stock to Neutral at $139.

On the other hand the company has Relative Strength Index (RSI 14) of 68.27 along with Average True Range (ATR 14) of 1.51, Consequently Johnson & Johnson (NYSE:JNJ)’s weekly and monthly volatility is 1.18%, 1.09% respectively. The company’s beta value is at 0.66.

In terms of Buy, Sell or Hold recommendations, Johnson & Johnson (NYSE:JNJ) has analysts’ mean recommendation of 2.3. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Johnson & Johnson (NYSE:JNJ)’s minimum EPS for the current quarter is at $1.96 and can go high up to $2.52. The consensus mean EPS for the current quarter is at $2.13 derived from a total of 14 estimates from the analysts who have weighed in on projected earnings. However the company reported $2.06 earnings per share for the same quarter during last year.

Previously Johnson & Johnson (NYSE:JNJ) reported $1.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.02. The company posted an earnings surprise of 1%.

Johnson & Johnson (NYSE:JNJ)’s revenue estimates for the current quarter are $19.62 Billion according to 11 number of analysts, for the current quarter the company has high revenue estimates of $19.93 Billion in contradiction of low revenue estimates of $19.25 Billion. For the current year the company’s revenue estimates are $81.16 Billion compared to low analyst estimates of $80.64 Billion and high estimates of $82.62 Billion according to 17 number of analysts.

Currently Johnson & Johnson (NYSE:JNJ)’s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 69.4%. However the six-month change in the insider ownership was recorded -16.07%, as well as three-month change in the institutional ownership was recorded 0.51%.

Johnson & Johnson (NYSE:JNJ)’s trailing twelve month revenues are $81.58 Billion, whereas its price to sales ratio for the same period is 4.56. Its book value per share for the most recent quarter is $22.31 while its price to book ratio for the same period is 6.25, as for as the company’s cash per share for the most recent quarter is $7.38, however its price to cash per share ratio for the same period is 18.88. The stock has 5 year expected PEG ratio of 3.58 whereas its trailing twelve month P/E ratio is 24.85.